- Home
- STG vs ICCC Comparison
STG vs ICCC Comparison
Compare STG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- ICCC
- Stock Information
- Founded
- STG 2003
- ICCC 1982
- Country
- STG China
- ICCC United States
- Employees
- STG N/A
- ICCC N/A
- Industry
- STG Other Consumer Services
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- ICCC Health Care
- Exchange
- STG Nasdaq
- ICCC Nasdaq
- Market Cap
- STG 73.4M
- ICCC 60.1M
- IPO Year
- STG 2018
- ICCC 1987
- Fundamental
- Price
- STG $9.20
- ICCC $6.37
- Analyst Decision
- STG
- ICCC
- Analyst Count
- STG 0
- ICCC 0
- Target Price
- STG N/A
- ICCC N/A
- AVG Volume (30 Days)
- STG 63.0K
- ICCC 15.9K
- Earning Date
- STG 08-14-2025
- ICCC 08-14-2025
- Dividend Yield
- STG N/A
- ICCC N/A
- EPS Growth
- STG N/A
- ICCC N/A
- EPS
- STG 3.09
- ICCC N/A
- Revenue
- STG $269,356,990.00
- ICCC $27,302,766.00
- Revenue This Year
- STG N/A
- ICCC N/A
- Revenue Next Year
- STG N/A
- ICCC N/A
- P/E Ratio
- STG $3.20
- ICCC N/A
- Revenue Growth
- STG N/A
- ICCC 28.29
- 52 Week Low
- STG $4.25
- ICCC $3.34
- 52 Week High
- STG $15.00
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- STG 50.13
- ICCC 45.40
- Support Level
- STG $10.08
- ICCC $6.25
- Resistance Level
- STG $11.50
- ICCC $7.30
- Average True Range (ATR)
- STG 1.57
- ICCC 0.35
- MACD
- STG -0.28
- ICCC -0.04
- Stochastic Oscillator
- STG 0.85
- ICCC 11.43
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.